Organovo Holdings, Inc. (NASDAQ:ONVO – Get Free Report) was the target of a significant decline in short interest in the month of July. As of July 15th, there was short interest totalling 80,000 shares, a decline of 18.7% from the June 30th total of 98,400 shares. Based on an average daily volume of 170,300 shares, the short-interest ratio is presently 0.5 days.
Organovo Stock Performance
ONVO stock remained flat at $0.57 on Tuesday. The company had a trading volume of 30,231 shares, compared to its average volume of 526,504. The company has a fifty day moving average of $0.81 and a two-hundred day moving average of $0.95. Organovo has a 52-week low of $0.55 and a 52-week high of $2.05. The company has a market cap of $8.12 million, a price-to-earnings ratio of -0.35 and a beta of 0.68.
Organovo (NASDAQ:ONVO – Get Free Report) last announced its quarterly earnings data on Friday, May 31st. The medical research company reported ($0.29) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.42) by $0.13. The business had revenue of $0.03 million for the quarter, compared to analyst estimates of $0.08 million. On average, equities research analysts forecast that Organovo will post -1.4 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Get Our Latest Report on Organovo
Organovo Company Profile
Organovo Holdings, Inc, a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture.
Featured Stories
- Five stocks we like better than Organovo
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- AbbVie Analysts Lead the Stock Higher as Humira Worries Recede
- What Are Dividends? Buy the Best Dividend Stocks
- Harley-Davidson Stock Revs Up With Billion Dollar Buyback Program
- How to Use Stock Screeners to Find Stocks
- Cruise Line Stock Sinks Despite Beating EPS and Raised Guidance
Receive News & Ratings for Organovo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo and related companies with MarketBeat.com's FREE daily email newsletter.